Board Meeting22 Oct 2026, 12:08 pm
Sun Pharma Advanced Research Board Meeting on Nov 2, 2026
AI Summary
Sun Pharma Advanced Research Company Ltd has announced that its Board of Directors will convene on November 2, 2026. The primary agenda item is the consideration and approval of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. Concurrently, the company has closed its trading window for designated personnel from October 1, 2026, until 48 hours after the financial results are declared, in compliance with SEBI's insider trading regulations.
Key Highlights
- Board meeting scheduled for November 2, 2026.
- To approve unaudited financial results for Q2 FY27.
- Trading window closure in effect until results announcement.
- Compliance with SEBI insider trading regulations.
Price Impact
More from SPARC